Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 3Thoracic 2Head & Neck 2Breast 2Other neoplasm 1

Conditions

Breast Neoplasms 2Fibrosis 1

Interventions

Trastuzumab 692Paclitaxel 678Cyclophosphamide 634Docetaxel 553Capecitabine 467Letrozole 407Carboplatin 392Fulvestrant 377Doxorubicin 330Tamoxifen 288pembrolizumab 270Anastrozole 252Epirubicin 249exemestane 238pertuzumab 226Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × alpha-Tocopherol × Breast × Clear all
NCT02898376 2018-08-08

FIBROTHERME

Institut de Cancérologie de Lorraine

Phase 3 Unknown
142 enrolled
Breast

Breast Neoplasms, Fibrosis

NCT00188669 2010-08-11

The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast Pain

University Health Network, Toronto

Phase 2 Terminated
48 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡